SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

B2 (B2) News

Follow B2 (B2) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol B2 Asset market Sector Markets 90 days 0 Updated Jul 06, 2026, 10:50 AM UTC Open live news feed
L Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to tre REGULATION | Jul 06, 2026, 10:50 AM UTC